	The clinical application potential assessment of the Deepseek-R1 large language model in lung cancer. Front Oncol Xu X, Liu Z, Zhou S, Ji B, Fan D, Yang Z, Chen H, Yang X, Guan M. PMID: 40963861 [PubMed]
	Efficacy of Radiotherapy FLASH-RT: From Treating Lung Cancer to Preventing Pulmonary Fibrosis. Dose Response Yang T, Xu Z, Hu W, Cao Z, Zhang Y. PMID: 40963699 [PubMed]
	Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of diffuse pleural mesothelioma: a systematic review and meta-analysis. Front Immunol Sun P, Song D, Ma N, Hou S, Liu L, Gao J, Tian Y. PMID: 40963599 [PubMed - indexed for MEDLINE]
	Breakthroughs in immune checkpoint therapy: overcoming NSCLC immune checkpoint therapy resistance with novel techniques. Front Immunol Kang LP, Huang HJ, Xu C, Chen HH, Huang DH, Jiang ZB. PMID: 40963596 [PubMed - indexed for MEDLINE]
	Prognostic Value of Handgrip Strength in Lung Cancer: Findings From a Multicenter Prospective Cohort Study. Cancer Control Wang X, Zhao H, Liang L, Gao Y, Song L, Shi H. PMID: 40963390 [PubMed - indexed for MEDLINE]
	There Is More Than Meets the Eye With Ground Glass Nodules: Is It Too Early to Adopt Sublobar Resection as Standard of Care for Early Stage Lung Adenocarcinoma? Thorac Cancer Leduc C. PMID: 40963366 [PubMed - indexed for MEDLINE]
	Real-World Evidence That Non-Smokers With High PD-L1 Non-Squamous NSCLC Have Poorer Outcomes With Immune Checkpoint Inhibitors. Thorac Cancer Kuo YC, Cheng WC, Chen HY, Chien CR, Tu CY, Chen HJ. PMID: 40963363 [PubMed - indexed for MEDLINE]
	Diagnostic Utility of Sampling Multiple Synchronous Pulmonary Nodules During Same-Session Robotic-Assisted Bronchoscopy. J Bronchology Interv Pulmonol Chrissian AA, Khosa J, Daher N, Heimbaugh C, Mirshahidi H, Leung A, Zaheer S, Bush D, Ho E. PMID: 40963299 [PubMed - indexed for MEDLINE]
	Inadequate Procedural Reporting Impairs Reporting of Quality Indicators in Bronchoscopy With Endobronchial Ultrasound. J Bronchology Interv Pulmonol Witt A, Rankin NM, Duong V, Webb AT, Stone E, Steinfort DP. PMID: 40963294 [PubMed - indexed for MEDLINE]
	Dual roles of amino acid metabolic reprogramming in chronic airway diseases and lung cancer: therapeutic opportunities and challenges. World J Surg Oncol Wang X, Zhang H. PMID: 40963133 [PubMed - indexed for MEDLINE]
	Revisiting LLMs and Lung Cancer Questions: How AI Responds to Common Lung Cancer Questions Two Years Later. Acad Radiol Nguyen D, Rahsepar AA, Chalian H, Hassani C, Kim GHJ, Bedayat A. PMID: 40962633 [PubMed - as supplied by publisher]
	Immune Checkpoint Inhibitor Without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A Real-World Retrospective Study. Clin Lung Cancer Gao M, Nie Y, Wang T, Jing F, Zhang F, Tao H, Ma J, Wang L, Hu Y. PMID: 40962612 [PubMed - as supplied by publisher]
	Prognostic implications of antitumour efficacy and adverse events of EGFR-TKIs in non-small cell lung cancer: an ambispective cohort study. Eur J Pharmacol Yong L, Liu Y, Jian W, Cai L, Bao T, Luo P, Gan E, Liu C, Wang T, Yao Q, Chen R, Cao B, Liu W, Zhou T. PMID: 40962011 [PubMed - as supplied by publisher]
	Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel Therapy in Patients With Genetic Alterations in Non-Small Cell Lung Cancer. Thorac Cancer Tanaka T, Tamiya M, Miyazaki A, Komura K, Futamura S, Kawamura T, Kunimasa K, Inoue T, Nishino K. PMID: 40961974 [PubMed - indexed for MEDLINE]
	Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for TTF-1 negative advanced nonsquamous non-small cell lung cancer: A multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102). Eur J Cancer Shiraishi Y, Shimose T, Tachihara M, Tsuchiya-Kawano Y, Morinaga R, Inoue H, Toi Y, Yamada T, Yamaguchi M, Kashiwabara K, Tobino K, Ishii H, Sakata Y, Inaba M, Nakashima K, Chibana K, Fukui T, Izumi M, Saito R, Ishii H, Omori S, Ogusu S, Furuyama K, Miura S, Harada T, Okamoto I. PMID: 40961811 [PubMed - as supplied by publisher]
	Reference standard methodology in the clinical evaluation of AI chest X-ray algorithms for lung cancer detection: A systematic review. Eur J Radiol Duncan SF, Kidd AC, Lampignano JP, Cannon P, Hall M, Stobo DB, Maclay JD, Blyth KG, Lowe DJ. PMID: 40961741 [PubMed - as supplied by publisher]
	Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors - Summary of recommendations. Respir Investig Okumura M, Fujimoto K, Hanaoka N, Kusumoto M, Omasa M, Shiono H, Tomiyama N, Kudo K, Tsujino K, Nihei K, Fukumoto K, Okuma Y, Takahashi S, Takemoto S, Funaki S, Shimizu S, Horiike A, Murakawa T. PMID: 40961648 [PubMed - as supplied by publisher]
	Previsit Preparation for Shared Decision-Making in Lung Cancer Screening in Primary Care Using a Paper Decision Aid and an Automated Text Messaging Program: Quasi-Experimental Pilot Study. JMIR Form Res Ito Fukunaga M, Wiener RS, Toomey S, Wagner J, Shi Q, Balakrishnan K, Nguyen A, Nguyen D, McKee MD, Bankier AA, Sadasivam RS, Crawford SL, Han PK, Houston TK, Mazor KM. PMID: 40961384 [PubMed - indexed for MEDLINE]
	Assessment of the interval between diagnosis and definitive treatment of lung cancer at a public institution in São Paulo. Rev Col Bras Cir Fiuza OR, Maior BSS, Moraes LB, Carvalho DAX, Perfeito JAJ, Evangelista Neto E, Miotto A. PMID: 40960752 [PubMed - indexed for MEDLINE]
	The mediating effect of hope between perceived social support and spiritual well-being in patients with early-stage lung cancer: A cross-sectional study. Support Care Cancer Huang P, Hu H, Wang J, Xu J, Li Y, Huang Y, He X, Hu W. PMID: 40960607 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 150954

Page 1 of 7548



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy